Petros Pharmaceuticals, Inc.

Petros Pharmaceuticals, Inc.verified

PTPI

Price:

$0.2846

Market Cap:

$2.85M

Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for the treatment of acute Peyronie's disease. The company markets its line of ED products in the form of vacuum erection device products. Petros Pharmaceuticals, Inc. is based in New York, New York.[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2020-12-02

Stock Exchange

NASDAQ

Ticker

PTPI

The PE Ratio as of December 2024 (TTM) for Petros Pharmaceuticals, Inc. (PTPI) is -0.07

According to Petros Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.07. This represents a change of -133.98% compared to the average of 0.21 of the last 4 quarters.

Petros Pharmaceuticals, Inc. (PTPI) Historical PE Ratio (quarterly & annually)

How has PTPI PE Ratio performed in the past?

The mean historical PE Ratio of Petros Pharmaceuticals, Inc. over the last ten years is -1.14. The current -0.07 PE Ratio has changed 514.24% with respect to the historical average. Over the past ten years (40 quarters), PTPI's PE Ratio was at its highest in in the March 2021 quarter at 3.02. The PE Ratio was at its lowest in in the June 2021 quarter at -3.56.

Quarterly (TTM)
Annual

Average

-1.14

Median

-0.29

Minimum

-3.88

Maximum

-0.12

Petros Pharmaceuticals, Inc. (PTPI) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Petros Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 890.42%

Maximum Annual PE Ratio = -0.12

Minimum Annual Increase = -95.40%

Minimum Annual PE Ratio = -3.88

Quarterly (TTM)
Annual
YearPE RatioChange
2023-0.38110.68%
2022-0.18-95.40%
2021-3.8886.81%
2020-2.07890.42%
2019-0.2170.50%

Petros Pharmaceuticals, Inc. (PTPI) Average PE Ratio

How has PTPI PE Ratio performed in the past?

The current PE Ratio of Petros Pharmaceuticals, Inc. (PTPI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-1.48

5-year avg

-1.34

10-year avg

-1.14

Petros Pharmaceuticals, Inc. (PTPI) PE Ratio vs. Peers

How is PTPI’s PE Ratio compared to its peers?

Petros Pharmaceuticals, Inc.’s PE Ratio is greater than Sunshine Biopharma, Inc. (-0.90), less than Guardion Health Sciences, Inc. (0.65), greater than Sonoma Pharmaceuticals, Inc. (-0.75), greater than Alpha Teknova, Inc. (-10.79), greater than Evoke Pharma, Inc. (-1.13), greater than Cumberland Pharmaceuticals Inc. (-2.91), greater than Agile Therapeutics, Inc. (-0.65), greater than PainReform Ltd. (-0.15), less than Mallinckrodt plc (-0.04), less than Lifecore Biomedical, Inc. (33.18), greater than Lucy Scientific Discovery Inc. (-1.23), greater than Alimera Sciences, Inc. (-20.50), greater than Adamis Pharmaceuticals Corporation (-0.67), greater than China Pharma Holdings, Inc. (-0.66), less than Halo Collective Inc. (-0.00), less than China SXT Pharmaceuticals, Inc. (-0.05), less than Akanda Corp. (-0.04), greater than GelStat Corporation (-3.76), greater than Shuttle Pharmaceuticals Holdings, Inc. (-0.19),

Build a custom stock screener for Petros Pharmaceuticals, Inc. (PTPI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Petros Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Petros Pharmaceuticals, Inc. (PTPI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Petros Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Petros Pharmaceuticals, Inc.'s PE Ratio?

How is the PE Ratio calculated for Petros Pharmaceuticals, Inc. (PTPI)?

What is the highest PE Ratio for Petros Pharmaceuticals, Inc. (PTPI)?

What is the 3-year average PE Ratio for Petros Pharmaceuticals, Inc. (PTPI)?

What is the 5-year average PE Ratio for Petros Pharmaceuticals, Inc. (PTPI)?

How does the current PE Ratio for Petros Pharmaceuticals, Inc. (PTPI) compare to its historical average?